Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

BACKGROUND & AIMS: Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 infection (COVID-19), remdesivir has been tried for a compassionate use in severe COVID-19. Newer randomized controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Singh, Akriti, Singh, Ritu, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214279/
https://www.ncbi.nlm.nih.gov/pubmed/32428865
http://dx.doi.org/10.1016/j.dsx.2020.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214279/
https://www.ncbi.nlm.nih.gov/pubmed/32428865
http://dx.doi.org/10.1016/j.dsx.2020.05.018

Ejemplares similares